D-0715-2018 Class III Terminated

Recalled by Mckesson Packaging Services — Concord, NC

FDA drug recall D-0715-2018 was initiated by Mckesson Packaging Services on Apr 23, 2018 and is designated Class III. Reason for recall: Failed Dissolution Specifications. High dissolution results were obtained during stability testing. The recall status is terminated (terminated Oct 13, 2020). Affected quantity: 7656 cartons.

Recall details

Product Type
Drugs
Report Date
May 2, 2018
Initiation Date
Apr 23, 2018
Termination Date
Oct 13, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7656 cartons

Product description

Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10

Reason for recall

Failed Dissolution Specifications. High dissolution results were obtained during stability testing.

Distribution pattern

Nationwide with the US

Code information

Lot #: 0114214, Exp. 09/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0715-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0715-2018. Report a data issue: hello@regdatalab.com.